Bifemelane hydrochloride is a pharmaceutical drug that has been used in Japan as an antidepressant and cerebral activator to treat depressive symptoms and cognitive disorders associated with cerebral infarction and senile dementia. It has also been explored for use in treating glaucoma. The drug was reportedly removed from the market in Japan in 1998 due to lack of proven effectiveness. Its therapeutic use is listed as antidepressants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include SON-216, Celeport and Alnert. Its PubChem CID is 6917789.
Bifemelane hydrochloride
| CAS No | 62232-46-6 |
|---|---|
| Molecular Formula | C18H24ClNO |
| Molecular Weight | 305.8 g/mol |
| Synonyms | 4-(2-benzylphenoxy)-N-methylbutan-1-amine;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bifemelane hydrochloride is a pharmaceutical drug that has been used in Japan as an antidepressant and cerebral activator to treat depressive symptoms and cognitive disorders associated with cerebral infarction and senile dementia.
The listed CAS number is 62232-46-6.
The listed molecular formula is C18H24ClNO.
The listed molecular weight is 305.8 g/mol.
4-(2-benzylphenoxy)-N-methylbutan-1-amine;hydrochloride.
The source lists SON-216, Celeport and Alnert.